FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120035328> ?p ?o ?g. }

• W2120035328 endingPage "246" @default.
• W2120035328 startingPage "238" @default.
• W2120035328 abstract "Abstract Purpose: Tumors grafted s.c. or under the mammary fat pad (MFP) rarely develop efficient metastasis. By applying bioluminescence imaging (BLI) technology, the MDA-MB-435-HAL-Luc subrenal capsule (SRC) model was compared with the MFP model for disease progression, metastatic potential, and response to therapy. Experimental Design: The luciferase-expressing MDA-MB-435-HAL-Luc cell line was used in both MFP and SRC models. BLI technology allowed longitudinal assessment of disease progression and the therapeutic response to PD-0332991, Avastin, and docetaxel. Immunohistochemical analysis of Ki67 and CD31 staining in the primary tumors was compared in these models. Caliper measurement was used in the MFP model to validate the BLI quantification of primary tumors. Results: The primary tumors in MDA-MB-435-HAL-Luc MFP and SRC models displayed comparable growth rates and vascularity. However, tumor-bearing mice in the SRC model developed lung metastases much earlier (4 weeks) than in the MFP model (&gt;7 weeks), and the metastatic progression contributed significantly to the survival time. In the MFP model, BLI and caliper measurements were comparable for quantifying palpable tumors, but BLI offered an advantage for detecting the primary tumors that fell below a palpable threshold and for visualizing metastases. In the SRC model, BLI allowed longitudinal assessment of the antitumor and antimetastatic effects of PD-0332991, Avastin, and docetaxel, and the results correlated with the survival benefits of these agents. Conclusions: The MDA-MB-435-HAL-Luc SRC model and the MFP model displayed differences in disease progression. BLI is an innovative approach for developing animal models and creates opportunities for improving preclinical evaluations of anticancer agents." @default.
• W2120035328 created "2016-06-24" @default.
• W2120035328 creator A5008118136 @default.
• W2120035328 creator A5038377138 @default.
• W2120035328 creator A5050105826 @default.
• W2120035328 creator A5055848575 @default.
• W2120035328 creator A5081727526 @default.
• W2120035328 date "2008-12-31" @default.
• W2120035328 modified "2023-09-26" @default.
• W2120035328 title "Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models" @default.
• W2120035328 cites W1232839958 @default.
• W2120035328 cites W1518520618 @default.
• W2120035328 cites W1520425169 @default.
• W2120035328 cites W1966542709 @default.
• W2120035328 cites W1967464554 @default.
• W2120035328 cites W1976689062 @default.
• W2120035328 cites W1979832956 @default.
• W2120035328 cites W1983396257 @default.
• W2120035328 cites W1988399840 @default.
• W2120035328 cites W1989076816 @default.
• W2120035328 cites W1995837249 @default.
• W2120035328 cites W1999060978 @default.
• W2120035328 cites W2010090802 @default.
• W2120035328 cites W2013788755 @default.
• W2120035328 cites W2017566393 @default.
• W2120035328 cites W2019011312 @default.
• W2120035328 cites W2020202068 @default.
• W2120035328 cites W2021951737 @default.
• W2120035328 cites W2038056960 @default.
• W2120035328 cites W2038341210 @default.
• W2120035328 cites W2046162983 @default.
• W2120035328 cites W2047887335 @default.
• W2120035328 cites W2057533148 @default.
• W2120035328 cites W2059614428 @default.
• W2120035328 cites W2062078476 @default.
• W2120035328 cites W2062494639 @default.
• W2120035328 cites W2063560639 @default.
• W2120035328 cites W2085739446 @default.
• W2120035328 cites W2090011934 @default.
• W2120035328 cites W2100088738 @default.
• W2120035328 cites W2115060752 @default.
• W2120035328 cites W2129884859 @default.
• W2120035328 cites W2142158452 @default.
• W2120035328 cites W214482553 @default.
• W2120035328 cites W2149262494 @default.
• W2120035328 cites W2154626333 @default.
• W2120035328 cites W2156363348 @default.
• W2120035328 cites W2156394189 @default.
• W2120035328 cites W2166753481 @default.
• W2120035328 cites W2172163796 @default.
• W2120035328 cites W2791242549 @default.
• W2120035328 doi "https://doi.org/10.1158/1078-0432.ccr-08-0897" @default.
• W2120035328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19118051" @default.
• W2120035328 hasPublicationYear "2008" @default.
• W2120035328 type Work @default.
• W2120035328 sameAs 2120035328 @default.
• W2120035328 citedByCount "40" @default.
• W2120035328 countsByYear W21200353282012 @default.
• W2120035328 countsByYear W21200353282013 @default.
• W2120035328 countsByYear W21200353282014 @default.
• W2120035328 countsByYear W21200353282015 @default.
• W2120035328 countsByYear W21200353282016 @default.
• W2120035328 countsByYear W21200353282017 @default.
• W2120035328 countsByYear W21200353282018 @default.
• W2120035328 countsByYear W21200353282019 @default.
• W2120035328 countsByYear W21200353282020 @default.
• W2120035328 countsByYear W21200353282021 @default.
• W2120035328 countsByYear W21200353282022 @default.
• W2120035328 countsByYear W21200353282023 @default.
• W2120035328 crossrefType "journal-article" @default.
• W2120035328 hasAuthorship W2120035328A5008118136 @default.
• W2120035328 hasAuthorship W2120035328A5038377138 @default.
• W2120035328 hasAuthorship W2120035328A5050105826 @default.
• W2120035328 hasAuthorship W2120035328A5055848575 @default.
• W2120035328 hasAuthorship W2120035328A5081727526 @default.
• W2120035328 hasConcept C111335760 @default.
• W2120035328 hasConcept C121608353 @default.
• W2120035328 hasConcept C126322002 @default.
• W2120035328 hasConcept C142724271 @default.
• W2120035328 hasConcept C143998085 @default.
• W2120035328 hasConcept C161997846 @default.
• W2120035328 hasConcept C204232928 @default.
• W2120035328 hasConcept C2775930923 @default.
• W2120035328 hasConcept C2778939058 @default.
• W2120035328 hasConcept C2779013556 @default.
• W2120035328 hasConcept C2779256057 @default.
• W2120035328 hasConcept C2780283643 @default.
• W2120035328 hasConcept C2781190966 @default.
• W2120035328 hasConcept C502942594 @default.
• W2120035328 hasConcept C530470458 @default.
• W2120035328 hasConcept C54009773 @default.
• W2120035328 hasConcept C54355233 @default.
• W2120035328 hasConcept C71924100 @default.
• W2120035328 hasConcept C81885089 @default.
• W2120035328 hasConcept C86803240 @default.
• W2120035328 hasConceptScore W2120035328C111335760 @default.
• W2120035328 hasConceptScore W2120035328C121608353 @default.
• W2120035328 hasConceptScore W2120035328C126322002 @default.

• next